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Introduction:During the last decade, thermal ablation techniques such as endovenous laser ablation have been challenging
the position of traditional surgery for the treatment of saphenous varicose veins. The newest method of thermal ablation
is pulsated steam, which works by heating the vein with steam at 120°C. This study assessed the effectiveness of steam
ablation of varicose veins in sheep and in humans.
Methods: The safety of the procedure in sheep was assessed by cardiovascular monitoring during treatment. We used
ultrasound imaging to examine occlusion of the veins. Changes in treated veins were examined microscopically. In a pilot
study, 20 veins in 19 patients with insufficiency of the great or the small saphenous vein were treated with pulsated steam
ablation. Anatomic success, patient satisfaction, and complications were investigated for 6 months after the procedure.
Results: All veins in the sheep were occluded. No cardiovascular changes occurred during treatment. Histologic examination
of treated veins showed typical changes of the vein wall, such as disappearance of the endothelial layer, fibrotic thrombosis, and
major alterations in collagen fibers in the media. Steam ablation was effective in the 19 patients: 13 of 20 veins were completely
closed, and 7 showed a very small segment of recanalization after 6 months of follow-up that did not seem to be clinically
relevant. Nine patients had some ecchymoses at the puncture site, and one patient had a transient superficial phlebitis. A median
maximal pain score of 1 (range, 0-10) was reported. No serious side effects, such as deep vein thrombosis, nerve injury, skin
burns, or infections, were reported. Patients were very satisfied with the treatment, with a median satisfaction score of 9.25
(range, 0-10).
Conclusions: In this proof-of-principle study, pulsated steam ablation was an effective treatment for saphenous varicose
veins. ( J Vasc Surg 2011;53:181-6.)
Clinical Relevance: This article describes a proof-of-principle study on the newest thermal endovascular treatment, steam
ablation. It describes the first group of patients treated with hyperheated steam of 120°C for ablation of saphenous
varicose veins. It also reports basic experimental data of this treatment on sheep to investigate the safety profile and the
morphologic and histologic changes resulting from steam ablation. Steam ablation in the patients was effective, safe, and
very well appreciated by the patients. This article describes the steam ablation procedure in humans, shows the first
results, and provides basic background information received from animal experiments.For more than a century, saphenous varicose veins have
been treated surgically with ligation and stripping of the
saphenous veins. During the last decade, however, minimally
invasive therapies for treating saphenous veins have been re-
placing traditional surgery, because they produce a lower
recurrence rate, higher health-related quality of life, higher
treatment satisfaction, and a lower complication rate.1 A com-
parative meta-analysis of four different therapies showed that
endovenous laser ablation (EVLA) was superior, followed by
nonsegmental radiofrequency ablation (RFA), ultrasound
(US)-guided foam sclerotherapy, and stripping, with success
rates of 95%, 80%, 74%, and 76%, respectively, after 5 years of
follow-up.2
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doi:10.1016/j.jvs.2010.06.171The mechanism of ablation in endovenous thermal ther-
apies such as EVLA and RFA is based on heating the venous
structure, and in EVLA, creating intravascular “steam bub-
bles.”3 The rise in temperature during EVLA is very high,
inducing blood carbonization, evaporation of the laser fiber
tip, and perforation of the venous wall.4 Patients also report
the taste of burned blood during EVLA. These observations
hypothesize that foreign material may stay within the body
and justify our search for other treatment modalities.
Steam ablation is a new method of thermal vein abla-
tion. Its objective is to achieve a safer and easier method of
thermal ablation that has fewer side effects. No studies have
reported on steam ablation yet. The present article de-
scribes a proof-of-principle study in which we assessed the
effectiveness and safety of steam ablation in animal experi-
ments and in a pilot study involving 19 patients with
varicose veins. The purpose of our studies was to assess
safety and effectiveness of steam ablation, first in animals
and then in patients, in a proof-of-principle study and to
investigate patient satisfaction of the steam treatment.
MATERIALS AND METHODS
For the steam ablation, the Steam Vein Sclerosis (SVS)
system (CERMA SA, Archamps France) was used. The SVS
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injects micropulses of steam into a catheter that delivers the
steam into the vein to be treated (Fig 1). A more detailed
description of the steam ablation procedure is given in
“Procedures” of the pilot study in patients. The procedure
in sheep was very similar to the procedure in humans.
Experiments in sheep
The sheep used in this study received care in compli-
ance with the FDA Good Laboratory Practice (GLP) reg-
Fig 1. Photographs show (A) the Steam Vein Sclerosis device,
(B) the steam generator, and (C) the steam catheter.ulations 21 CFR 58 (revised April 1, 2005).The experiments in sheep consisted of two parts. The
first was a safety assessment during steam ablation by caval
vein blood temperature measurement, subcutaneous tem-
perature measurement, and monitoring of hemodynamic
parameters. The second part consisted of measurements of
the vein diameter by US imaging for 3 months after the
steam treatment and microscopic investigation of treated
veins after euthanasia of the sheep.
Steam ablation procedure. The steam ablation in six
sheep was performed under general and tumescent (sterile
saline with 1% lidocaine) anesthesia. To measure perivenous
temperature, sensors were inserted under the skin close to
the saphenous vein. Sensors were placed inside two veins to
measure initial and final intravascular temperatures. During
treatment, electrocardiography, arterial blood pressure, heart
rate, and oxygen saturation were monitored. In one sheep, a
temperature-monitoring catheter was inserted into the con-
tralateral saphenous vein and threaded up into the inferior
caval vein to measure blood temperature during steam ablation.
A US examination was performed to measure the vein
diameter before, immediately after, and at 1 and 3 months.
Macroscopic examination was performed immediately,
20 days after, or 3 months after the treatment.
On four of the six sheep undergoing the steam ablation
procedure, we performed US examination to measure di-
ameter shrinkage; two of these four sheep were used for
intravascular temperature measurement, two were used for
perivenous temperature measurement, and all four sheep
were used for macroscopic examination. These four sheep
were euthanized 3 months after steam ablation. Two other
sheep (2462 and 41083) were used for macroscopic exam-
ination (one with excision of a small part of the vein
immediately after treatment) for perivenous temperature
measurements and one also for caval vein temperature
measurement. These two sheep were euthanized 20 days
after treatment. Hemodynamic parameters were measured
in all six sheep. To test the validity of the animal study, two
veins from two of the sheep were treated with RFA in a
standard fashion.
Pilot study
Patients. The pilot study included 20 veins of 19
consecutive patients presenting at our Department of Der-
matology with primary insufficiency of the great saphenous
vein (GSV) or short saphenous vein (SSV) with typical
complaints such as tired legs and heaviness, defined by
reflux time0.5 seconds and a vein diameter5 mm. The
exclusion criteria for patients included age18 years, acute
deep or superficial vein thrombosis, agenesis of deep vein
system, vascular malformations or syndromes, occlusive
postthrombotic syndrome, pregnancy, immobility, allergy
to lidocaine, and arterial insufficiency (ankle-brachial index
0.9). In the Netherlands, the introduction of a new
medical device with a CE registration number, such as the
SVS system, does not require permission of the medical
ethical committee.
Procedure. The procedure of steam ablation is very
similar to EVLA. Steam ablation was performed with the
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setting. The vein was punctured with a 16-gauge infusion
needle under US guidance. The insufficient GSV was mostly
entered at or just above knee level because access is easy at
that site and the risk of nerve injury is small. The SSV was
entered halfway or at the distal third part of the calf,
depending on vein diameter. After puncturing the vein, the
steam catheter (1.2-mm diameter) was passed through
the hollow needle into the vein until positioned 3 cm below
the junction. The most pivotal step in the procedure is
positioning the echo-dense tip of the sheath approximately
3 cm distally from the junction under longitudinal US
visualization.
About 150 to 300 mL (depending on the length of vein
treated) of tumescent anesthesia (5 mL epinephrine [5 mL
bicarbonate] and 35 mL lidocaine 1% diluted in 500 mL
saline solution) was administered into the perivenous space
under US guidance using a mechanical infusion pump.
Tumescent anesthesia is necessary because it reduces pain,
cools perivenous tissue, and decreases the venous diameter.
After activation, the catheter releases small “puffs” of
steam, and the catheter was pulled back stepwise. With the
first activation 3 cm below the (saphenofemoral or saphe-
nopopliteal) junction, four puffs of steam were adminis-
tered, meanwhile with manual pressure on the junction.
Two puffs of steam were administered at 1-cm intervals.
During the first 4 cm of treatment, manual compression on
the junction was still applied. After the first 12 treatments,
we reduced the amount of administered energy to one puff
per further cm in patients with a vein diameter 8 mm.
This was because a few patients reported the sensation of
feeling heat during the treatment and because good results
with using less energy in smaller veins was observed during
the evolution of the method.
A physicist calculated that approximately 2258 J is re-
leased when 1 g of steam condenses. In EVLA, it is considered
consensus to apply about 50 to 60 J/cm. To occlude 30 cm of
vein with steam ablation, theoretically, 1 to 1.5 mL of water is
needed. In practice, 2 to 5 mL of water is likely to be required,
because not all steam condenses at the vein wall.
The steam is produced by means of piston pressing a
fixed amount of water (76 L diameter piston stroke)
through a heated element located just before the catheter.
By keeping the lumen diameters very small and the exit
holes even smaller, pressure is maintained and loss of energy
is limited. The volume of the steam depends on the pressure
Table I. Steam ablation in sheep, treatment parameters
Sheep No. Limb Puffs/cm Withdrawal (cm)
2462 Right 3 1
2462 Left 1 1
41083 Right 3 1
41083 Left 2 1
SD, Standard deviation.and temperature. As the energy is transferred to the vein,the steam cools and condenses to the same volume of water
used to produce the steam. The steam starts to cool and
condense when it leaves the catheter due to the drop in
pressure and the exchange of energy with the surroundings.
This process is dynamic. The theoretic amount of energy of
one pulse of steam is 174 J. The measured amount released
at the tip of the catheter is 60 J per pulse. However,
additional dose-finding studies are warranted.
After the procedure, patients were advised to wear
thigh-length medical elastic compression stockings (pres-
sure range, 25-35 mm Hg) for 1 week and to mobilize
immediately after the treatment.
Statistical analysis. Variables were presented in means
with standard deviation (SD) if distributed parametrically,
or as median with the 25th and 75th percentile value
(interquartile range [IQR]) if distributed nonparametri-
cally. We compared the scores of the EuroQol quality-of-
life questionnaire (EQ-5D) index and visual analog scale
(VAS),5 Aberdeen Varicose Vein Questionnaire (AVVQ),6
and Venous Clinical Severity Score (VCSS)7 before and 3
months after therapy using the Wilcoxon signed-rank test.
We performed statistical analysis with SPSS 15.0 software
(SPSS Inc, Chicago, Ill) and assigned significance at P 
.05 (two-sided P).
RESULTS
Experiments in sheep
Safety. The treatment parameters for four treated
limbs are summarized in Table I. No temperature rise was
observed at the level of the vena cava inferior in sheep
41083. In sheep 2462, a temperature rise from 30° to
59°C was observed with the subcutaneous thermocouple
in the left limb and from 30° to 32°C in the right limb.
The temperature rise was from 30° to 38°C in the right
and left limb of sheep 41083. Noninvasive arterial blood
pressure, heart rate and oxygen saturation remained
stable during treatment in all sheep. Only a transient
lower oxygen saturation was observed in the right limb
of sheep 41083. The intravascular temperature increased
at the end of the procedure in one of two veins from
36.4° to 40°C.
Morphologic changes in vein diameter. Before
treatment, the diameters of the veins varied between 0.28
and 0.35 cm. US examination demonstrated that all veins
were occluded and that the diameter of each vein decreased
Total energy (J) Energy (J/cm)
Total puffs (No.) Mean (SD) Mean (SD)
42 1592 (67) 114 (4.8)
24 910 (38) 38 (1.6)
39 1474 (35) 59 (1.4)
42 1588 (38) 76 (1.8)directly after the steam ablation. The diameters continued
40
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diameter of 56% (SD, 4.8%) after 3 months (Table II).
Microscopic examination. Microscopic examination
of veins immediately after the steam ablation showed dis-
appearance of the endothelial layer, with negative marking
for factor VIII and a few cleavage zones in the media (Fig 2,
A) Microscopic examination of treated veins that were
Fig 2. Photomicrographs show a vein (A) immediately
treatment with steam ablation (both hematoxylin-eosin
eosin stain, original magnification 200). D, Photomi
ablation (hematoxylin-eosin stain, original magnification
Table II. Morphologic changes measured by ultrasound e
Sheep No. Limb Energy (J/cm) Before Tx A
2872 Right 40 0.28
3347 Left 80 0.32
2343 Right 40 0.34
2343 Left 80 0.35
1481 Right 80 0.31
1481 Left 40 0.33
Mean (SD) NA 0.32 (0.18) 0.
NA, Not applicable; SD, standard deviation; Tx, treatment.removed 20 days after the steam ablation showed endothe-lial destruction, fibrotic thrombosis with inflammatory re-
action of the media, major alterations of elastic and collagen
fibers in the media, and lesions in the adventitia with
liponecrosis and lipogranuloma (Fig 2, B and C) Locally,
the inflammatory reaction extended to the adventitia.
Three months after the steam ablation, microscopic exam-
ination showed (major) thickening of the vein wall with
treatment with steam ablation and (B) at 20 days after
, original magnification 40). C, Detail (hematoxylin-
aph shows a vein 3 months after treatment with steam
).
ination
in diameter, cm
Tx At 1 mon At 3 mon Difference after 3 mon
0.17 0.15 0.13
0.28 0.18 0.14
0.21 0.22 0.12
0.23 0.15 0.20
0.18 0.18 0.13
0.20 0.19 0.14
.13) 0.21 (0.29) 0.18 (0.19) 0.14 (0.19)after
stain
crogrxam
Ve
fter
0.25
0.28
0.29
0.27
0.28
0.25
27 (0fibrosis and inflammation, destruction of endothelium, al-
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mented histiocytes, a significant reduction of the lumen,
and capillary neovessels. There were also focal areas in
which the endothelium was preserved (Fig 2, D). The
observed histologic changes were similar to those found
after treatment with RFA.
Pilot study
Study population. The study comprised 19 patients
(7 women) who were a mean age of 53 years (Table III). Of
the 20 veins treated, 17 were GSV and 3 were SSV. More
than half of the treated patients were considered clinical
class 2 of the CEAP classification.
Outcomes. The mean treated length of the veins was
25 cm, and an average of 50 pulses of steam were adminis-
tered per treated vein (Table III). All treated veins were
occluded on US examination at 1 week. At 3 months, 1 of
the 20 treated varicose veins showed a small segment of
several centimeters with minimal blood flow. At 6 months,
flow was observed on US examination in 7 of 20 treated
saphenous veins, but this was a small string (never filling the
entire venous diameter) over a tract of10 cm. In only two
of seven cases did the strings of flow show minimal reflux.
At the 1-week follow-up, there were no cases of deep vein
thrombosis, skin burns, nerve injury, infections, or hyperpig-
mentation. One patient had transient superficial phlebitis dis-
tally from the treated part, and nine patients had some ecchy-
mosis only at the puncture site, but not along the treated vein.
No complications were reported by the patients or were
detected with US at 3 and 6 months of follow-up.
The median VCSS decreased significantly from 5.0
(IQR 3.3, 9.3) to 2.5 (IQR 1.0, 5.0) 3 months after the
treatment (P .001; Fig 3). Of the three patients in whom
the VCSS remained identical, the absolute scores were 2,
10, and 14. The AVVQ improved significantly from 12.6
(IQR 6.9, 25.1) to 9.8 (IQR 2.1, 17.9; P  .027). Al-
Table III. Patient characteristics
Variable No. or Mean (SD)
Patients 19
Legs 20
GSV 17
SSV 3
Age, y 53 (15)
Sex
Female 12
Male 7
CEAP
C2 11
C3 2
C4 4
C5 2
C6 0
Treated length, cm 25 (7)
Pulses, No. 50 (19)
GSV, Great saphenous vein; SD, standard deviation; SSV, small saphenous
vein.though the EQ-5D index improved 3 months after thetreatment in eight patients and deteriorated in one, the
difference was not significant (P  .11). The VAS of
the EQ-5D did not change considerably after steam abla-
tion (median remained 80 of 100, P  .56). Median
satisfaction of the treatment was 9.25 (IQR 8.6, 10.0) and
median maximal pain after steam ablation was 1 (IQR 0, 2)
on a 10-point VAS. Four patients used four to six analgesics
(500 mg paracetamol or a nonsteroidal anti-inflammatory
drug) daily 1 or 2 days after the treatment.
DISCUSSION
In this study, we have described the first results of a new
technique to ablate varicose veins using high-temperature
steam, which appears to be safe, effective, and appreciated
by patients.
In sheep veins treated with steam ablation, fibrosis and
destruction of the vein was confirmed by histology, and
ongoing fibrotic contraction was confirmed by shrinking of
vein diameter on US imaging. The similar histologic
changes found after heating using the RFA technique show
that our study design was valid and very much in line with
previous observations.8
In the 20 veins treated in the patients, 13 were com-
pletely occluded and 7 showed minor recanalization on US
examination at 6 months of follow-up. Although the num-
ber of partial recanalizations increased from 1 to 7 between
3 and 6 months of follow-up, the clinical relevance of this
finding is unclear. The observed flow on US examination
was limited and may reflect a process of venous remodelling
as is observed after RFA. This deterioration emphasizes the
need for clinical dose-finding studies in SVS (ie, number of
steam pulses/cm).
Many observational studies—but few randomized con-
trolled trials—have shown the high efficacy of EVLA, and a
recent meta-analysis of all available data after an adjustment
for follow-up demonstrated that EVLA was more effective
than stripping, RFA, and US-guided foam sclerotherapy.2
Only two publications have reported radiofrequency-
powered segmental thermal ablation, which has a heating
element of 7 cm. The first was a case series that showed
Fig 3. The positive, neutral, and negative impact of steam abla-
tion is shown on the Venous Clinical Severity Score (VCSS),
Aberdeen Varicose Vein Questionnaire (AVVQ), and the EuroQol
quality-of-life questionnaire (EQ-5D) index and visual analog scale
(VAS), four measures of clinical and health-related quality-of-life.occlusion rates of 99% after 6 months of follow-up.9 The
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EVLA with radiofrequency-powered segmental ablation
measuring posttreatment recovery and quality-of-life pa-
rameters, in which the authors concluded that the radio-
frequency-powered segmental ablation was superior.10 Be-
cause thermal endovenous treatments are very effective, the
challenge is now to search for the one that is the safest,
cheapest, and most appreciated by patients and physicians
(optimal risk-benefit ratio).
Our second finding concerned the safety of steam
ablation, which was demonstrated by stable hemodynamic
parameters and low perivenous temperatures in the sheep
during steam ablation, and neither did the 19 patients have
any major complications, such as DVT or nerve injury. Two
other features that might be advantageous compared with
EVLA are that steam ablation is performed with a very small
volume of sterile water (approximately 2 mL per treated
vein) and that the temperature is relatively constant, with a
maximum of 120°C. Carbonized blood is released during
EVLA, and the temperature is very variable, rising to 600°
to 1000°C, and sometimes even melting the fiber tip.11
The steam catheter, in contrast, is introduced directly
through the puncturing needle, without the need for a
guidewire or sheath, resulting in an easier and safer proce-
dure. There is less risk of device-related complications, such
as the retention of a guidewire inside the body, which has
been reported in EVLA.12-13
The patient-reported outcomes suggest that steam abla-
tion was very well tolerated. The pain scores were low, and
patients were very satisfied with the treatment. The clinical
disease severity, as measured by the VCSS, improved signifi-
cantly, and the AVVQ disease-specific questionnaire showed a
significant improvement after steam ablation. Whether these
patient-reported outcomes are better than with EVLA and
RFA has to be assessed in a comparative study.
An advantage of the steam-ablation procedure is that
the catheter is minute and very flexible. The diameter of the
SVS steam catheter (1.2 mm) is almost 50% smaller than
that of the segmental RFA (2.33 mm). The flexibility may
facilitate placement of the catheter into branches, tortuous
vessels, and perforator veins, which are sometimes difficult
to access with the more rigid catheters used in RFA and the
stiff glass fibers used in EVLA. The steam is released from
two small areas at the tip of the catheter, allowing treatment
of any length of vein, which is not possible with the
segmental RFA with a 7-cm-long stiff heating tip. The
steam is released under pressure and, therefore, disperses
over a distance of at least 2 cm. This may be of additional
benefit in the treatment of short perforator veins and short
segments of meandering veins.
The limitations of this study were the limited number
of treated limbs and the lack of comparison with established
methods. The main objective was, however, not to prove
superiority over another method but to show that the steam
ablation of the saphenous veins is feasible to perform safely
in animals and humans with satisfactory short-term results.
Larger comparative studies are needed to compare thelong-term efficacy and the risk-benefit ratio of steam abla-
tion with those of existing endovenous techniques.
CONCLUSION
Steam ablation of the saphenous vein using the SVS is a
novel method of endovenous thermal ablation. It appears
to be safe, effective, and highly appreciated by patients. It
may potentially have advantages over currently available
thermal therapies.
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